Hoth Therapeutics, Inc. (HOTH)

–

USD

–(–)

Open

$0.876

Prev. Close

$0.84

High

$0.93

Low

$0.876

Company Profile

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.

CEORobb Knie

Sector

Recently from Cashu

Healthcare

IndustryBiotechnology

Employees6

IPO DateFeb 15, 2019

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

Address1177 Avenue of the Americas

City / State / ZIPNew York, NY, 10036

CountryUnited States

Phone646 756 2997

Websitehttps://www.hoththerapeutics.com